|
1
|
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
$129M
|
-$35.8M
|
-716,449
|
-21%
|
|
|
2
|
|
$107M
|
–
|
–
|
–
|
|
|
3
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$62.6M
|
-$150
|
-3
|
-0%
|
|
|
4
|
Adage Capital Partners
Boston,
Massachusetts
|
$61.5M
|
+$7.29M
|
+145,781
|
+13%
|
|
|
5
|
Paradigm Biocapital Advisors
New York
|
$59.8M
|
+$63.6M
|
+1,272,279
|
New
|
|
|
6
|
Novo Holdings A/S
Hellerup,
Denmark
|
$51.2M
|
–
|
–
|
–
|
|
|
7
|
Perceptive Advisors
New York
|
$42.1M
|
+$7.64M
|
+152,803
|
+21%
|
|
|
8
|
State Street
Boston,
Massachusetts
|
$31.3M
|
+$26.4M
|
+527,898
|
+379%
|
|
|
9
|
Vanguard Group
Malvern,
Pennsylvania
|
$31.3M
|
+$5.29M
|
+105,685
|
+19%
|
|
|
10
|
Frazier Life Sciences Management
Palo Alto,
California
|
$30.8M
|
–
|
–
|
–
|
|
|
11
|
|
$30.3M
|
+$7.09M
|
+141,782
|
+28%
|
|
|
12
|
Polar Capital Holdings
London,
United Kingdom
|
$25.7M
|
+$27.4M
|
+546,915
|
New
|
|
|
13
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$24.8M
|
+$16.3M
|
+325,069
|
+160%
|
|
|
14
|
Janus Henderson Group
London,
|
$23.5M
|
+$50
|
+1
|
+0%
|
|
|
15
|
5AM Venture Management
San Francisco,
California
|
$20.6M
|
-$2.5M
|
-50,000
|
-10%
|
|
|
16
|
Deerfield Management
New York
|
$20.2M
|
–
|
–
|
–
|
|
|
17
|
Rock Springs Capital Management
Baltimore,
Maryland
|
$17.1M
|
–
|
–
|
–
|
|
|
18
|
Citadel Advisors
Miami,
Florida
|
$14.6M
|
-$17.1M
|
-340,889
|
-52%
|
|
|
19
|
Fidelity Investments
Boston,
Massachusetts
|
$14.3M
|
-$881K
|
-17,621
|
-5%
|
|
|
20
|
Foresite Capital Management V
Larkspur,
California
|
$11.4M
|
–
|
–
|
–
|
|
|
21
|
Cormorant Asset Management
Boston,
Massachusetts
|
$10.6M
|
–
|
–
|
–
|
|
|
22
|
Geode Capital Management
Boston,
Massachusetts
|
$10.1M
|
+$3.37M
|
+67,343
|
+46%
|
|
|
23
|
|
$7.57M
|
+$2.53M
|
+50,581
|
+46%
|
|
|
24
|
Franklin Resources
San Mateo,
California
|
$7.56M
|
+$188K
|
+3,766
|
+2%
|
|
|
25
|
Ikarian Capital
Dallas,
Texas
|
$6.71M
|
-$4.87M
|
-97,265
|
-41%
|
|
